Scientists discover that a cancer's greatest strength—rampant protein production—can be its fatal flaw in Atypical Teratoid/Rhabdoid Tumors.
Exploring how proteasome inhibitor MG132 affects NK/T cell lymphoma cells by disrupting their protein recycling system and inducing cell cycle arrest.